Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy
The goal of this clinical study is to determine the impact of starting the use of the FreeStyle Libre 2 glucose monitoring system, over a three month period, on HbA1c in adults with type 2 diabetes treated with a basal insulin regimen.
- EligibilityCriteria: Inclusion Criteria:  Aged ≥18 to ≤ 75 years. Type 2 diabetes diagnosis ≥1 year prior to enrolment. Type 2 diabetes treated with a basal insulin injection regimen with or without other antihyperglycaemic therapy at enrolment. Current glucose lowering treatment regimen has been established for at least 3 months prior to enrolment. Screening HbA1c ≥59 mmol/mol to ≤108 mmol/mol (≥7.5% and ≤12.0%, inclusive), within the last 60 days.  Exclusion Criteria:  Participant is currently prescribed prandial or pre-mixed (biphasic) insulin at enrolment. Currently participating in another study that could affect glucose measurements or glucose management. Currently receiving dialysis treatment or receives dialysis during the study. A female participant who is pregnant. A breastfeeding female participant. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult